ArticleDiscover oncology2025

The molecular mechanism of gemcitabine in inhibiting the HIF-1α/VEGFB/FGF2/FGFR1 signaling pathway for ovarian cancer treatment.

Liangliang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.